News
Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated
Cumberland Pharmaceuticals Inc.announced the publication of data from a clinical trial evaluating the pharmacokinetics, safety and tolerability of a rapid infusion of Caldolor® (ibuprofen) Injection compared to oral ibuprofen. The study, which was published in the January issue of...
News
BioSante Pharmaceuticals, Inc. To Present LibiGel® Safety Study Update At BIO CEO & Investor Conference
BioSante Pharmaceuticals, Inc. will be presenting at the 2011 BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the 13th Annual CEO & Investor Conference will take place February 14-15, 2011 at the Waldorf-Astoria in New...
News
First African country introduces GSK’s pneumococcal vaccine through innovative financing mechanism
GlaxoSmithKline (GSK) announced the incorporation of its pneumococcal vaccine into the Kenyan national immunisation programme. Kenya is the first African country to receive pneumococcal vaccines through the innovative financing mechanism known as the Advance Market Commitment (AMC), which is...
News
BIOTRONIK introduces new unique Reliaty Pacing System Analyzer
BIOTRONIK SE & Co. KG, announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer (PSA) is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators (ICDs) and...
News
Tobotec Signs Multiple Agreements With Generic Manufacturers To Provide New HIV Treatment
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational...
News
Innovation drives Novartis to double-digit growth for 2010
Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies, or cc) to USD 50.6 billion. Solid sales growth in fourth quarter, operating income impacted by one-offs and A(H1N1) pandemic flu vaccine sales in...
News
Aurobindo Pharma receives USFDA approval for Levofloxacin Tablets
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the US Food & Drug Administration to manufacture and market Levofloxacin tablets 250mg, 500mg and 750mg. Levofloxacin tablets 250mg, 500mg and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
